BACKGROUND: Physician values regarding the benefit of continued medical therapy vs colectomy for moderate ulcerative colitis have not been defined. If physicians perceive these states differently than patients, their therapeutic recommendations may not align with patient values. OBJECTIVE: This study aimed to compare physician and patient willingness to trade life years with moderately active ulcerative colitis vs undergoing colectomy. DESIGN: This survey of physicians' and patients' utility values used standardized scenarios for moderately active ulcerative colitis and colectomy. SETTING: The investigation was conducted at a tertiary academic medical center. METHODS: Gastroenterologists, colorectal surgeons, and patients with ulcerative colitis who were either living with moderate disease or were postcolectomy completed the survey. MAIN OUTCOME MEASURES: Utility values were measured by the use of the time trade-off method. RESULTS: We surveyed 17 physicians, 150 postcolectomy patients, and 69 patients with moderate ulcerative colitis. Utility values for ulcerative colitis and colectomy states were (0.87, 0.95), (0.86, 0.92), and (0.91, 0.91). On average, physicians and postcolectomy patients assessed the utility of life with ulcerative colitis more poorly than the postcolectomy state. Patients with moderately active ulcerative colitis who had not undergone colectomy viewed both health states equally. LIMITATIONS: This study was limited by the physician subject sample size. CONCLUSIONS: Patients living with moderate ulcerative colitis value the pre- and postcolectomy states differently than physicians and postcolectomy patients. Recognizing the differences between their own and patients' values may help physicians to better counsel patients preoperatively. In addition, exposure to postcolectomy patients may help those with moderate disease who are weighing the comparative benefits of colectomy.
BACKGROUND: Physician values regarding the benefit of continued medical therapy vs colectomy for moderate ulcerative colitis have not been defined. If physicians perceive these states differently than patients, their therapeutic recommendations may not align with patient values. OBJECTIVE: This study aimed to compare physician and patient willingness to trade life years with moderately active ulcerative colitis vs undergoing colectomy. DESIGN: This survey of physicians' and patients' utility values used standardized scenarios for moderately active ulcerative colitis and colectomy. SETTING: The investigation was conducted at a tertiary academic medical center. METHODS: Gastroenterologists, colorectal surgeons, and patients with ulcerative colitis who were either living with moderate disease or were postcolectomy completed the survey. MAIN OUTCOME MEASURES: Utility values were measured by the use of the time trade-off method. RESULTS: We surveyed 17 physicians, 150 postcolectomy patients, and 69 patients with moderate ulcerative colitis. Utility values for ulcerative colitis and colectomy states were (0.87, 0.95), (0.86, 0.92), and (0.91, 0.91). On average, physicians and postcolectomy patients assessed the utility of life with ulcerative colitis more poorly than the postcolectomy state. Patients with moderately active ulcerative colitis who had not undergone colectomy viewed both health states equally. LIMITATIONS: This study was limited by the physician subject sample size. CONCLUSIONS:Patients living with moderate ulcerative colitis value the pre- and postcolectomy states differently than physicians and postcolectomy patients. Recognizing the differences between their own and patients' values may help physicians to better counsel patients preoperatively. In addition, exposure to postcolectomy patients may help those with moderate disease who are weighing the comparative benefits of colectomy.
Authors: A J Muir; L J Edwards; L L Sanders; R R Bollinger; M J Koruda; D R Bachwich; D Provenzale Journal: Am J Gastroenterol Date: 2001-05 Impact factor: 10.864
Authors: Arthur S Elstein; Gretchen B Chapman; Joan S Chmiel; Sara J Knight; Cheeling Chan; Robert B Nadler; Timothy M Kuzel; Amy K Siston; Charles L Bennett Journal: Health Expect Date: 2004-06 Impact factor: 3.377
Authors: James D Harrison; Michael J Solomon; Jane M Young; Alan Meagher; Phyllis Butow; Glenn Salkeld; George Hruby; Stephen Clarke Journal: Arch Surg Date: 2008-04
Authors: Casey J Allen; Danny Yakoub; Francisco Igor Macedo; Austin R Dosch; Jessica Brosch; Vikas Dudeja; Ronda Ayala; Nipun B Merchant Journal: Ann Surg Date: 2018-10 Impact factor: 12.969
Authors: Meenakshi Bewtra; Vikram Kilambi; Angelyn O Fairchild; Corey A Siegel; James D Lewis; F Reed Johnson Journal: Inflamm Bowel Dis Date: 2014-01 Impact factor: 5.325